News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News EuroPCR 2012 CIBELES: Xience Stands Up to Cypher for CTO PCI Caitlin E. Cox May 17, 2012
News Conference News EuroPCR 2012 Strong Showing for Bioabsorbable-Scaffold DES Caitlin E. Cox May 16, 2012
News Conference News EuroPCR 2012 Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations Jason Kahn May 15, 2012
Presentation Fellows 2012 Stent Restenosis and Thrombosis: Etiology, Treatment, and Outcomes Presenter: Ajay Kirtane April 22, 2012
Presentation GI2 2012 Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis Presenter: Marco V. Wainstein April 12, 2012
Presentation GI2 2012 The Controversy: DES vs DEB for In-Stent Restenosis Presenter: Pedro A. Lemos April 11, 2012
Presentation GI2 2012 Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment Presenter: Jose Ribamar Costa April 11, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
Presentation ACC 2012 A Double Blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis Presenter: Antonio Colombo March 25, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
News Daily News El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico March 15, 2012
News Daily News El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF March 13, 2012
Presentation Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After DES Implantation Presenter: H. Song March 12, 2012
News Daily News Stent Thrombosis Risk Lower with Xience vs. First-Generation DES Yael L. Maxwell March 06, 2012
News Daily News It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions Jason Kahn March 06, 2012